[1] J.G. Kenna, K.S. Taskar, C. Battista, D.L. Bourdet, K.L.R. Brouwer, K.R. Brouwer, D. Dai, C. Funk, M.J. Hafey, Y. Lai, J. Maher, Y.A. Pak, J.M. Pedersen, J.W. Polli, A.D. Rodrigues, P.B. Watkins, K. Yang, R.W. Yucha. Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective. Clinical Pharmacology & Therapeutics 104 (2018) 916-932. https://doi.org/10.1002/cpt.1222 DOI: https://doi.org/10.1002/cpt.1222

[2] C. Saran, K.L.R. Brouwer. Hepatic Bile Acid Transporters and Drug-induced Hepatotoxicity. Toxicologic Pathology 51 (2023) 405-413. https://doi.org/10.1177/01926233231212255 DOI: https://doi.org/10.1177/01926233231212255

[3] R. Chan, L.Z. Benet. Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI. Toxicological Sciences 162 (2018) 499-508. https://doi.org/10.1093/toxsci/kfx284 DOI: https://doi.org/10.1093/toxsci/kfx284

[4] X. Chu, K. Korzekwa, R. Elsby, K. Fenner, A. Galetin, Y. Lai, P. Matsson, A. Moss, S. Nagar, G.R. Rosania, J.P. Bai, J.W. Polli, Y. Sugiyama, K.L. Brouwer. Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver. Clinical Pharmacology & Therapeutics 94 (2013) 126-141. https://doi.org/10.1038/clpt.2013.78 DOI: https://doi.org/10.1038/clpt.2013.78

[5] S. Jain, M. Grandits, L. Richter, G.F. Ecker. Structure based classification for bile salt export pump (BSEP) inhibitors using comparative structural modeling of human BSEP. Journal of Computer-Aided Molecular Design 31 (2017) 507-521. https://doi.org/10.1007/s10822-017-0021-x DOI: https://doi.org/10.1007/s10822-017-0021-x

[6] R.E. Morgan, C.J. van Staden, Y. Chen, N. Kalyanaraman, J. Kalanzi, R.T. Dunn, C.A. Afshari, H.K. Hamadeh. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological Sciences 136 (2013) 216-241. https://doi.org/10.1093/toxsci/kft176 DOI: https://doi.org/10.1093/toxsci/kft176

[7] J.M. Pedersen, P. Matsson, C.A. Bergström, J. Hoogstraate, A. Norén, E.L. LeCluyse, P. Artursson. Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11). Toxicological Sciences 136 (2013) 328-343. https://doi.org/10.1093/toxsci/kft197 DOI: https://doi.org/10.1093/toxsci/kft197

[8] F. Montanari, M. Pinto, N. Khunweeraphong, K. Wlcek, M.I. Sohail, T. Noeske, S. Boyer, P. Chiba, B. Stieger, K. Kuchler, G.F. Ecker. Flagging Drugs That Inhibit the Bile Salt Export Pump. Molecular Pharmaceutics 13 (2016) 163-171. https://doi.org/10.1021/acs.molpharmaceut.5b00594 DOI: https://doi.org/10.1021/acs.molpharmaceut.5b00594

[9] R. Rodríguez-Pérez, G. Gerebtzoff. Identification of bile salt export pump inhibitors using machine learning: Predictive safety from an industry perspective. Artificial Intelligence in the Life Sciences 1 (2021) 100027. https://doi.org/10.1016/j.ailsci.2021.100027 DOI: https://doi.org/10.1016/j.ailsci.2021.100027

[10] R. Geci, A.Z. Sayin, S. Schaller, et al. Integration of in vitro and in silico approaches enables prediction of drug-induced liver injury. Archives of Toxicology 100 (2026) 2029-2046. https://doi.org/10.1007/s00204-026-04305-2 DOI: https://doi.org/10.1007/s00204-026-04305-2

[11] V.M.P. de Bruijn, I.M.C.M. Rietjens, H. Bouwmeester. Population pharmacokinetic model to generate mechanistic insights in bile acid homeostasis and drug-induced cholestasis. Archives of Toxicology 96 (2022) 2717-2730. https://doi.org/10.1007/s00204-022-03345-8 DOI: https://doi.org/10.1007/s00204-022-03345-8

[12] K.S. McLoughlin, C.G. Jeong, T.D. Sweitzer, A.J. Minnich, M.J. Tse, B.J. Bennion, J.E. Allen, S. Calad-Thomson, T.S. Rush, J.M. Brase. Machine learning models to predict inhibition of the bile salt export pump. Journal of Chemical Information and Modeling 61 (2021) 587-602. https://doi.org/10.1021/acs.jcim.0c00950 DOI: https://doi.org/10.1021/acs.jcim.0c00950

[13] H. Liu, R.N. Irobalieva, J. Kowal, et al. Structural basis of bile salt extrusion and small-molecule inhibition in human BSEP. Nature Communications 14 (2023) 7296. https://doi.org/10.1038/s41467-023-43109-1 DOI: https://doi.org/10.1038/s41467-023-43109-1

[14] K.L. Valko. Biomimetic chromatography - A novel application of the chromatographic principles. Analytical Science Advances 3 (2022) 146-153. https://doi.org/10.1002/ansa.202200004 DOI: https://doi.org/10.1002/ansa.202200004

[15] K. Valko, S. Nunhuck, C. Bevan, M.H. Abraham, D.P. Reynolds. Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity. Journal of Pharmaceutical Sciences 92 (2003) 2236-2248. https://doi.org/10.1002/jps.10494 DOI: https://doi.org/10.1002/jps.10494

[16] F. Tsopelas, C. Stergiopoulos, A. Tsantili-Kakoulidou. Immobilized artificial membrane chromatography: from medicinal chemistry to environmental sciences. ADMET and DMPK 6 (2018) 225-241. https://doi.org/10.5599/admet.553 DOI: https://doi.org/10.5599/admet.553

[17] C. Stergiopoulos, F. Tsopelas, K. Valko. Prediction of hERG inhibition of drug discovery compounds using biomimetic HPLC measurements. ADMET and DMPK 9 (2021) 191-207. https://doi.org/10.5599/admet.995 DOI: https://doi.org/10.5599/admet.995

[18] S. Dawson, S. Stahl, N. Paul, J. Barber, J.G. Kenna. In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug Metabolism and Disposition 40 (2012) 130-138. https://doi.org/10.1124/dmd.111.040758 DOI: https://doi.org/10.1124/dmd.111.040758

[19] OECD. Guidance Document on the Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models, OECD Publishing, Paris, France, 2014. https://doi.org/10.1787/9789264085442-en DOI: https://doi.org/10.1787/9789264085442-en

[20] J. Ghuman, P.A. Zunszain, I. Petitpas, A.A. Bhattacharya, M. Otagiri, S. Curry. Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology 353 (2005) 38-52. https://doi.org/10.1016/j.jmb.2005.07.075 DOI: https://doi.org/10.1016/j.jmb.2005.07.075